Structural Formula (Fos01 0004 01)
Foscavir Injection, Solution
Product Images NDC 76310-024
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Foscavir (NDC 76310-024). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Clinigen Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Logos (Fos01 0004 02)
Bottle Label (PRINCIPAL DISPLAY PANEL)
Carton Label (PRINCIPAL DISPLAY PANEL)
This is the product information for FOSCAVIR® (foscarnet sodium) injection, with a concentration of 6000 mg/250 mL (24 mg/mL). It is intended for intravenous infusion only and must be diluted for peripheral intravenous infusion. The solution is sterile, non-pyrogenic, and should be stored between 20° and 25°C. The usual dose information can be found in the package insert, with administration precautions specifying controlled intravenous infusion at a rate no more than 1 mg/kg/minute. It is distributed by Hospira Inc. in the USA and manufactured by Clinigen Healthcare in the UK.*
Fos01 0004 05
This text provides information about Foscavir®, a medication used for intravenous infusion. It contains details about the composition of the drug, storage instructions, dosage, administration precautions, and proper dilution guidelines for IV use. Foscavir® is distributed by Hospra in the USA and Clinigen in the UK.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
